Skip to main content
Caplight Logo









Nephrolyx

Nephrolyx

Private
BerlinHealthcare & Life Scienceshttps://www.nephrolyx.com/

Last Round

Seed

Dec 1, 2023

Total Funding Raised

$1.11M

Company Overview

Nephrolyx is a medical supplies company that develops and provides precise glomerular filtration rate (GFR) measurement solutions for clinical and research applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Clinical Trials, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware + Subscription, Data as a Service

AI Layer

Application

Keywords

glomerular filtration rateGFRmeasured GFRmGFRin-vitro diagnosticIVDkidney function testiohexol clearancerenal diagnosticslaboratory information management systemLIMSprecision medicineclinical trial softwareAKI detectiondigital biomarker

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nephrolyx Comparables

Compare Nephrolyx with similar companies based on industry and business-model similarity.

Nephrolyx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Accunea Ltd
78%
MediBeacon
76%
numares Health
71%

Nephrolyx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 1, 2023
SeedJul 5, 2023
AcceleratorOct 1, 2022
AcceleratorMay 19, 2022

Key People

Founding team and executive leadership

Bartosz Reinhold

Chief Operating Officer Founder

Founding Team

Markus Riester

Chief Executive Officer

Executive Team

Nephrolyx Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 29, 2024

    Monthly visitors increased 176% MoM.

  • Mar 3, 2024

    Grew 38% QoQ, from 8 to 11 employees.

Nephrolyx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nephrolyx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nephrolyx's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin
Employee Range10
Year Founded2019
Last FundingDec 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?